West Nile Virus (WNV) remains the leading mosquito-borne disease threat in the continental United States, with cases consistently spiking during late summer months. This seasonal pattern, driven by optimal breeding conditions including regular rainfall, high humidity, and warm temperatures, demands proactive mosquito control strategies and clear community communication.
Data reported to the Centers of Disease Control (CDC) by state health departments each year highlights the historical trend for a late summer uptick in West Nile Virus cases (see chart):

WNV disease incidence reported to the CDC by week of illness onset, 1999-2022. Source: ArboNET, Arboviral Diseases Branch, Centers for Disease Control and Prevention.
This data reveals a consistent late summer surge in West Nile Virus cases, typically peaking between July and September. This predictable timeline allows integrated mosquito management programs to implement targeted surveillance and control measures before disease transmission escalates.
Today, we’re covering the steps an integrated mosquito management program should take to ensure early detection and prompt communications and control, including targeted adult mosquito control measures and preventive larval interventions.
Effective West Nile Virus prevention begins with comprehensive mosquito surveillance. Professional surveillance traps continuously monitor regional mosquito populations, with collected specimens transported to certified laboratories for species identification and disease testing using RAMP or PCR diagnostic methods.
When surveillance testing confirms West Nile Virus presence in local mosquito populations, immediate action becomes critical. Positive test results indicate potential human transmission risk, triggering coordinated adult mosquito control treatments and targeted larval control in known breeding sites.
Learn more about how mosquito-borne disease surveillance testing and labs, including Clarke’s own PCR testing lab, operate here.

If mosquito samples test positive for West Nile Virus, that means there’s potential for the virus to transfer to humans through the bite of an infected mosquito.
Adult mosquito control treatments can help reduce the public health threat. If local or regional mosquitoes begin testing positive for WNV, many communities elect to schedule a preventative treatment to protect residents from the disease threat. It may also be appropriate to perform larval control in known breeding areas to prevent future transmission.
The CDC is the most credible source of information on West Nile Virus.
According to the CDC, approximately 80% of West Nile Virus infections remain asymptomatic. Among those who develop symptoms (roughly 20% of cases), common signs include:
Severe cases, affecting about 1 in 150 infected individuals, can progress to encephalitis or meningitis. Older adults and individuals with compromised immune systems face elevated risks, with approximately 10% of severe cases resulting in death.
If you have these physical symptoms, the CDC recommends seeking medical treatment.

The CDC recommends these protective measures to protect against West Nile Virus transmission:
When West Nile Virus cases emerge in communities, clear and immediate public communication becomes essential for protecting residents and preventing panic. Municipal leaders need professional-grade resources to deliver accurate, timely information about disease risks and prevention measures.
Clarke’s comprehensive public relations kit provides municipal customers with everything needed to inform and reassure constituents during vector-borne disease outbreaks. This professional resource package includes:
Request your free West Nile Virus Public Relations kit.
Professional mosquito control programs play an indispensable role in protecting public health, especially during late summer months when West Nile Virus transmission risk peaks. Combined with proactive community communication and individual protective measures, comprehensive mosquito management ensures residents can safely enjoy outdoor activities while minimizing disease exposure risks.